(Philadelphia, PA) - Daniel Heitjan, PhD, has joined the Department of Biostatistics and Epidemiology at the University of Pennsylvania School of Medicine as a Professor of Biostatistics.

Prior to his faculty appointment with Penn, Dr. Heitjan held teaching positions at Columbia University, Penn State University and University of California, Los Angeles. He was also the Director of Biostatistics for the International Center for Health Outcomes Innovation and Research and the Director of Biostatistics Resource for the Herbert Irving Comprehensive Cancer Center, both divisions of Columbia University, New York City.

Dr. Heitjan earned his MSc and PhD degrees in Statistics from the University of Chicago in 1984 and 1985, respectively. His research interests focus on statistical methods for the design and analysis of medical studies, but his collaborative work has predominately been in cancer and cardiac surgery. Dr. Heitjan is the recipient of two National Institutes of Health grants, one to develop methodology for outcomes research studies linked to clinical trials; and another to develop methods for diagnosing sensitivity to nonignorability in studies with missing data.

He has authored or co-authored numerous papers in peer-reviewed journals including the New England Journal of Medicine, Statistical Science, Journal of the American Statistical Association and Statistics in Medicine. He is currently a statistical consultant to the Annals of Internal Medicine; member of the Editorial Board of Statistics in Medicine; and member of the panel of statistical editors at the Journal of the National Cancer Institute.

He is a member of several professional organizations including the American Statistical Association (ASA), Biometric Society and the Society for Clinical Trials. His accolades include Fellow of ASA, the Stanley S. Schor Visiting Scholar Award from Merck Research Laboratories; National Merit Scholar; Centers for Disease Control (CDC) and Agency for Toxic Substances and Disease Registry (ATSDR) Statistics Award; and Program Chair for the ASA Biometrics Section, among others. Dr. Heitjan is married with three children.

# # #


Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.